UiPath Inc. stocks have been trading down by -12.21 percent amid bearish sentiment over slowing automation software demand.
Click Here for a Millionaire's POV on Trading PATH
SUBSCRIBE FOR ALERTSJOIN 50,000+ ACTIVE TRADERS
Key Takeaways For UiPath Traders
- UBS lowered its PATH price target from $13 to $12 but kept a Neutral rating, signaling slightly weaker upside expectations.
- Recent PATH trading shows a sharp fade from above $12 to near $10.56, highlighting fragile sentiment.
- UiPath fundamentals show strong gross margins and solid cash, but growth is being repriced at lower multiples.
- Low debt and positive free cash flow give PATH room to ride out sentiment swings, yet near-term direction remains uncertain.
Live Update At 12:33:20 EDT: On Wednesday, July 22, 2026 UiPath Inc. stock [NYSE: PATH] is trending down by -12.21%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.
Quick Financial Overview
PATH has been grinding lower on the chart, and the numbers explain why traders are cautious but not walking away. In the most recent quarter ending 2026/04/30, UiPath posted about $418.4M in revenue and roughly $22.5M in net profit. That works out to a small profit margin, but it marks a clear shift from the heavy losses many high‑growth software names carried a few years ago.
Gross margin near 83% tells traders this is still a classic high-margin software model. Operating income was around $27.9M, and EBITDA came in near $52.8M, signaling that the core business is generating real cash. Free cash flow of about $129.2M, plus roughly $632.2M in cash and over $1.3B in cash and short-term investments, gives PATH a sizable cushion.
More Breaking News
- Cerebras Systems (CBRS) Stock Jumps As Flex Deal Turbocharges AI Capacity
- OTLK Stock Slips As Warrant Resale Overhang Builds
- CPHI Stock Whipsaws As Company Denies Hidden News
- Rivian Stock Jumps As RIVN Hikes 2026 Delivery Outlook
On the balance sheet, total debt is low, with long-term debt only about $72.0M and total liabilities near $1.0B against $2.9B in assets. Valuation-wise, PATH trades at roughly 3.2 times sales and about 10 times free cash flow, far below the nosebleed levels of earlier years. For traders, that combination means UiPath is no longer a story stock; it is a real business being priced more like a maturing software name than a hyper-growth rocket.
Why Traders Are Watching PATH After The UBS Move
The latest catalyst is the UBS haircut. The firm trimmed its UiPath price target from $13 to $12 while keeping a Neutral rating. That’s not a disaster headline, but it does send a message. Big money desks are shaving expectations for PATH, not slapping a screaming sell on it, yet clearly not ready to call it a leader in the current AI software wave.
On the daily chart, PATH recently opened at $12.02 and closed at $10.5601, a nasty intraday fade that lines up neatly with this cautious tone. Over the past couple of weeks, the stock has churned between roughly $10.5 and $12.5, with repeated failures to hold pushes above $12.50. Traders reading this tape see supply hitting every bounce, which fits with a lowered price target and lukewarm analyst stance.
Intraday, PATH slid steadily from the $12 premarket area to around $11.50 off the open and then bled toward $10.56 through the session. That’s classic distribution action: early strength sold into, followed by lower highs all day. For short-term traders, UiPath is acting like a name in repricing mode as Wall Street nudges its targets down.
At the same time, UBS kept PATH at Neutral, not Underperform. That hints at a tug-of-war. The business has real revenue growth, strong gross margins, and solid cash. But the market is demanding cheaper AI automation exposure, so every rally toward prior targets is getting sold. Active traders who thrive on volatility will keep PATH on screen precisely because that push‑pull can create clean, repeatable intraday patterns.
Conclusion
UiPath sits in a tricky spot for traders. The fundamentals are strong enough that PATH is not getting thrown in the trash, yet sentiment is soft enough that big firms like UBS are walking their targets down from $13 to $12. The chart agrees. PATH is failing to hold the $12s, putting pressure on anyone who chased strength, while offering short setups for traders who respect the trend.
At the same time, the balance sheet and cash flow picture mean UiPath is not a broken company. PATH has over $1.3B in liquidity, low debt, and positive free cash flow. That gives the company time to keep building its automation platform while the market figures out what multiple it deserves. For traders, that translates into a name where sentiment, not survival, is the key driver.
This is exactly the type of chart-driven scenario Tim Sykes and Tim Bohen talk about all the time: “You don’t need to predict the future, you just need to react faster than everyone else.” As Tim Bohen, lead trainer with StocksToTrade says, “A good trade setup checks all the boxes—volume, trend, catalyst. Don’t trade if you’re missing pieces of the puzzle.”. With PATH, that means watching how price behaves around the $10.50 support area and the $12 resistance band. UiPath will continue to draw active traders as long as those levels keep breaking, failing, and resetting — offering disciplined players short-term opportunities in both directions, strictly for educational and research purposes and never as investment advice.
This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.
Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.
Check out our quick startup guide for new traders!
- How to Read Stock Charts: A Guide for Beginners
- Trading Plan: 6 Steps to Create One
- How To Create a Stock Watchlist
Ready to build your watchlists? Check out these curated lists:
Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.